Clindamycin Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Antibiotic Prophylaxis in Rhinoplasty
Conditions: Nasal Obstruction; Nasal Surgical Procedures Interventions: Drug: Intra-operative single intravenous(iv) dose of cephalexin 2 g or clindamycin 900 mg.; Drug: Intra-operative single intravenous dose of cephalexin 2 g or clindamycin 900 mg + Postoperative oral dose for a duration of 3 days of cephalexin 250mg Q4H or clindamycin 150mg Q6H. Sponsors: Stanford University; Washington University School of Medicine; Université de Montréal Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 11, 2019 Category: Research Source Type: clinical trials

Antibiotic Prophylaxis in Rhinoplasty
Conditions: Nasal Obstruction; Nasal Surgical Procedures Interventions: Drug: Intra-operative single intravenous(iv) dose of " cephalexin " 2 g or " clindamycin " 900 mg.; Drug: Intra-operative single dose (iv) of " cephalexin " 2 g or " clindamycin " 900 mg and postoperative oral dose of " cephalexin " 250mg (every 4 hours) or " clindamycin " 150mg(every 6 hours) for 3 days Sponsors: Stanford University; Washington University School of Medicine; Université de Montréal Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 11, 2019 Category: Research Source Type: clinical trials

Bio-equivalence Study With Clinical Endpoints in the Treatment of Acne Vulgaris
Condition: Acne Vulgaris Interventions: Drug: CLPG Topical Gel 1%; Drug: Clindamycin; Drug: Placebo Sponsor: Taro Pharmaceuticals USA Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 22, 2019 Category: Research Source Type: clinical trials